AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26636393 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimized extracorporeal circulation (MECC)
Number of subjects: 120
Study 26636393 — intervention group
Group type: EXPERIMENTAL
Intervention: Off‐pump coronary artery bypass grafting (OPCAB)
Number of subjects: 120
Study 26636393 — intervention group
Group type: COMPARATOR
Intervention: Heparin management
Number of subjects: 120
Study 26636393 — intervention group
Group type: COMPARATOR
Intervention: Overall renal function parameters
Number of subjects: 120
Study 24851845 — intervention group
Group type: EXPERIMENTAL
Intervention: Earplug technique
Number of subjects: 90
Study 24851845 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 90
Study 24851845 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 22569432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral L-carnitine (LC) supplementation, 250 mg tablets three times a day for eight weeks
Number of subjects: 30
Study 22569432 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 20485941 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive reinforcement during spirometry (only in intervention group)
Number of subjects: 105
Study 20485941 — intervention group
Group type: COMPARATOR
Intervention: Control group (no positive reinforcement)
Number of subjects: 105
Study 18823152 — intervention group
Group type: COMPARATOR
Intervention: Testosterone modified to match levels of younger men for 6 weeks; conversion of testosterone to estradiol blocked; production of testosterone blocked; placebo (no treatment)
Number of subjects: 0
Study 16022960 — intervention group
Group type: EXPERIMENTAL
Intervention: Antitachycardia pacing
Number of subjects: 431
Study 16022960 — intervention group
Group type: COMPARATOR
Intervention: Shock therapy
Number of subjects: 431
Study 16022960 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LBBB
Number of subjects: 431
Study 16022960 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RBBB and nonspecific IVCD
Number of subjects: 431
Study 12512893 — intervention group
Group type: EXPERIMENTAL
Intervention: Preradiotherapy ventilation tube insertion
Number of subjects: 0
Study 12512893 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 0
Study 10513773 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 392
Study 10513773 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab (reteplase)
Number of subjects: 392
Study 8953409 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal ointment
Number of subjects: 0
Study 8953409 — intervention group
Group type: COMPARATOR
Intervention: Plain drug ointment
Number of subjects: 0
Study 8953409 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal formulations with ultrasound
Number of subjects: 0
Study 2007326 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril 20 mg
Number of subjects: 206
Study 2007326 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 206
Study 2007326 — intervention group
Group type: COMPARATOR
Intervention: Benazepril 2, 5, and 10 mg
Number of subjects: 206
Study 2007326 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label Hydrochlorothiazide (25 mg/day) added to benazepril, hydrochlorothiazide, or placebo
Number of subjects: 206
Study 7097736 — intervention group
Group type: EXPERIMENTAL
Intervention: 45‐minute videotape lecture discussing practical issues of the diagnosis and management of children with meningomyelocele
Number of subjects: 78
Study 7097736 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 78
Study 31420350 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxy polyethylene glycol-epoetin beta
Number of subjects: 2818
Study 31420350 — intervention group
Group type: COMPARATOR
Intervention: Reference erythropoiesis-stimulating agents
Number of subjects: 2818
Study 28829488 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 74
Study 28829488 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 74
Study 26027881 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective node dissection (ipsilateral neck dissection at the time of primary surgery)
Number of subjects: 500
Study 26027881 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic node dissection (watchful waiting followed by neck dissection for nodal relapse)
Number of subjects: 500
Study 23642145 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated care program (Care Navigation)
Number of subjects: 500
Study 23642145 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 500
Study 21302117 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical bowel occlusion (no-touch group)
Number of subjects: 32
Study 21302117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no surgical bowel occlusion)
Number of subjects: 32
Study 21302117 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups with saline irrigation of 400 ml or more
Number of subjects: 32
Study 19530582 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicryl Plus (antibacterial suture)
Number of subjects: 100
Study 19530582 — intervention group
Group type: COMPARATOR
Intervention: Vicryl (traditional braided suture)
Number of subjects: 100
Study 17352567 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intoxication group
Number of subjects: 101
Study 17352567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-intoxication group
Number of subjects: 101
Study 17352567 — intervention group
Group type: COMPARATOR
Intervention: No-intoxication control group
Number of subjects: 101
Study 17352567 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intoxication group
Number of subjects: 101
Study 12913686 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcostal mini incision donor nephrectomy
Number of subjects: 82
Study 12913686 — intervention group
Group type: COMPARATOR
Intervention: Transcostal mini incision donor nephrectomy
Number of subjects: 82
Study 10481417 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol injected at a rate of 800 ml/hr after fentanyl 100 micrograms
Number of subjects: 55
Study 10481417 — intervention group
Group type: COMPARATOR
Intervention: Propofol injected at a rate of 1 ml/s after fentanyl 100 micrograms
Number of subjects: 55
Study 8984708 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 400 micrograms
Number of subjects: 10
Study 8984708 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 800 micrograms
Number of subjects: 10
Study 8984708 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 1250 micrograms
Number of subjects: 10
Study 8984708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8984708 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms
Number of subjects: 10
Study 8984708 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 1250 micrograms
Number of subjects: 10
Study 1681840 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 micrograms kg‐1
Number of subjects: 107
Study 1681840 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.08 mg kg‐1
Number of subjects: 107
Study 1681840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 6751243 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulphate
Number of subjects: 27
Study 6751243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 31411972 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-day percentage erection fullness score (0-24% or 25-100%)
Number of subjects: 388
Study 31411972 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-day percentage erection fullness score
Number of subjects: 388
Study 31648845 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial combination therapy (ambrisentan and tadalafil)
Number of subjects: 500
Study 31648845 — intervention group
Group type: COMPARATOR
Intervention: Pooled monotherapy (ambrisentan or tadalafil)
Number of subjects: 500
Study 28481761 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Expressive Writing
Number of subjects: 109
Study 28481761 — intervention group
Group type: COMPARATOR
Intervention: Traditional Expressive Writing
Number of subjects: 109
Study 28481761 — intervention group
Group type: COMPARATOR
Intervention: Control Writing Condition
Number of subjects: 109
Study 25950389 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative subpterygial Mitomycin C injection (0.1mL 0.015% MMC)
Number of subjects: 83
Study 25950389 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative subpterygial Mitomycin C injection (0.1mL 0.015% MMC)
Number of subjects: 83
Study 24321802 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART regimen (budesonide-formoterol 200 μg and 6 μg per actuation, twice daily, plus as needed)
Number of subjects: 303
Study 24321802 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART regimen
Number of subjects: 303
Study 22125425 — intervention group
Group type: EXPERIMENTAL
Intervention: Double cervical cerclage (addition to McDonald cerclage)
Number of subjects: 0
Study 22125425 — intervention group
Group type: COMPARATOR
Intervention: McDonald cerclage
Number of subjects: 0
Study 19938213 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear acupuncture stimulation
Number of subjects: 14
Study 19938213 — intervention group
Group type: COMPARATOR
Intervention: Sham-point control
Number of subjects: 14
Study 17067979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol (50 mg capsules, 3 times daily for a total of 150 mg daily) for 8 weeks
Number of subjects: 39
Study 17067979 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment during the observation period)
Number of subjects: 39
Study 15526380 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium (1.156x10(‐7) mol/L) for 6 h in vitro or selenium-yeast (200 microg/d) for 8-12 wk
Number of subjects: 0
Study 15526380 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-yeast (200 microg/d) for 8-12 wk
Number of subjects: 0
Study 15526380 — intervention group
Group type: COMPARATOR
Intervention: Healthy blood donors (control group)
Number of subjects: 0
Study 15526380 — intervention group
Group type: COMPARATOR
Intervention: Chronic hepatitis patients (without selenium treatment)
Number of subjects: 0
Study 10740417 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin and neuropeptide Y concentrations in pregnant women with EPH gestosis
Number of subjects: 87
Study 10740417 — intervention group
Group type: COMPARATOR
Intervention: Leptin and neuropeptide Y concentrations in healthy pregnant women
Number of subjects: 87
Study 10740417 — intervention group
Group type: COMPARATOR
Intervention: Leptin and neuropeptide Y concentrations in healthy non-pregnant women
Number of subjects: 87
Study 10740417 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of plasma NPY concentration in pregnant women with EPH gestosis
Number of subjects: 87
Study 10740417 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of leptinaemia in pregnant women
Number of subjects: 87
Study 7862419 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% levocabastine
Number of subjects: 50
Study 7862419 — intervention group
Group type: COMPARATOR
Intervention: 4% sodium cromolyn
Number of subjects: 50
Study 1778192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1778192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 20
Study 7011467 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of dipyridamole in combination with 30 mg (0.5 mg/kg) of acetylsalicylic acid (ASA)
Number of subjects: 36
Study 7011467 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of dipyridamole in combination with 50 mg (0.8 mg/kg) of acetylsalicylic acid (ASA)
Number of subjects: 36
Study 7011467 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of dipyridamole in combination with 160 mg (2.6 mg/kg) of acetylsalicylic acid (ASA)
Number of subjects: 36
Study 7011467 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of dipyridamole in combination with 330 mg (5.7 mg/kg) of acetylsalicylic acid (ASA)
Number of subjects: 36
Study 7011467 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole alone
Number of subjects: 36
Study 7011467 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole-ASA combinations with ASA doses of 0.5 to 0.8 mg/kg
Number of subjects: 36
Study 7011467 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole-ASA combinations with ASA doses between 2.6 to 5.7 mg/kg
Number of subjects: 36
Study 31029154 — intervention group
Group type: EXPERIMENTAL
Intervention: TLP0-001 in combination with S-1
Number of subjects: 185
Study 31029154 — intervention group
Group type: COMPARATOR
Intervention: Placebo in combination with S-1
Number of subjects: 185
Study 29795561 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTM treatment
Number of subjects: 36
Study 29795561 — intervention group
Group type: COMPARATOR
Intervention: Other treatments (not rhTM)
Number of subjects: 36
Study 29795561 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in HMGB1
Number of subjects: 36
Study 26698157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon application time of 240 seconds (group 1)
Number of subjects: 114
Study 26698157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon application time of 180 seconds (group 2)
Number of subjects: 114
Study 25239028 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise in hypoxic conditions (simulating 3000 m)
Number of subjects: 11
Study 25239028 — intervention group
Group type: COMPARATOR
Intervention: Cycling exercise in ambient conditions (975 m)
Number of subjects: 11
Study 25239028 — intervention group
Group type: EXPERIMENTAL
Intervention: Both hypoxic and ambient cycling exercise
Number of subjects: 11
Study 23114134 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates combined with chemotherapy
Number of subjects: 53
Study 23114134 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 53
Study 19757018 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm and Replens lubricant gel
Number of subjects: 2452
Study 17721099 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART (Highly Active Antiretroviral Therapy)
Number of subjects: 1160
Study 15612942 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (PerioGard)
Number of subjects: 16
Study 15612942 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% hydrogen peroxide (Peroxyl)
Number of subjects: 16
Study 15612942 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined chlorhexidine+hydrogen peroxide
Number of subjects: 16
Study 15612942 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 16
Study 12170139 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastoid cortex plasty with scutum plasty and insertion of a Silastic sheet
Number of subjects: 35
Study 12170139 — intervention group
Group type: COMPARATOR
Intervention: Scutum plasty with insertion of a Silastic sheet without mastoid cortex plasty
Number of subjects: 35
Study 12170139 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without mastoid cortex plasty)
Number of subjects: 35
Study 9989957 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 339
Study 9989957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study 7586249 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 0
Study 7586249 — intervention group
Group type: COMPARATOR
Intervention: Coronary surgery
Number of subjects: 0
Study 7586249 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 0
Study 31197287 — intervention group
Group type: EXPERIMENTAL
Intervention: Volleyball training for athletes with intellectual disabilities
Number of subjects: 30
Study 31197287 — intervention group
Group type: COMPARATOR
Intervention: Healthy players
Number of subjects: 30
Study 29231318 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30
Study 29231318 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 30
Study 29231318 — intervention group
Group type: COMPARATOR
Intervention: Healthy Control
Number of subjects: 30
Study 26556081 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (15 minutes running at 65-75% HRmax)
Number of subjects: 57
Study 26556081 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial stress group (working on a standard intelligence test under stress)
Number of subjects: 57
Study 26556081 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular class session)
Number of subjects: 57
Study 22885913 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.65 g/kg)
Number of subjects: 12
Study 22885913 — intervention group
Group type: COMPARATOR
Intervention: Non-alcohol condition
Number of subjects: 12
Study 21850690 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) and corticosteroids (arm 1; n = 77)
Number of subjects: 295
Study 21850690 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF), TAC, and corticosteroids (arm 2; n = 72)
Number of subjects: 295
Study 21850690 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF), TAC, and daclizumab induction with no corticosteroids (arm 3; n = 146)
Number of subjects: 295
Study 21850690 — intervention group
Group type: COMPARATOR
Intervention: Steroid-free immunosuppression (arm 3)
Number of subjects: 295
Study 21850690 — intervention group
Group type: COMPARATOR
Intervention: All arms (1, 2, and 3)
Number of subjects: 295
Study 19644398 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil-based (OL) lipid emulsion
Number of subjects: 44
Study 19644398 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil (SO) lipid emulsion
Number of subjects: 44
Study 17960954 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 0.5mg/day
Number of subjects: 709
Study 17960954 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 100mg/day plus adefovir 10mg/day for those with virologic breakthrough
Number of subjects: 709
Study 17960954 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir
Number of subjects: 709
Study 17960954 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy for treatment-naive patients (lamivudine plus adefovir)
Number of subjects: 709
Study 15578509 — intervention group
Group type: COMPARATOR
Intervention: Conventional percutaneous ethanol injection (PEI)
Number of subjects: 157
Study 15578509 — intervention group
Group type: COMPARATOR
Intervention: Higher-dose percutaneous ethanol injection (PEI)
Number of subjects: 157
Study 15578509 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) ablation
Number of subjects: 157
Study 12575553 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Bushen Huoxue herbs (YQBSHX)
Number of subjects: 200
Study 12575553 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 9597406 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable angina pectoris patients
Number of subjects: 859
Study 9597406 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 859
Study 9597406 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable angina pectoris patients (males)
Number of subjects: 859
Study 7842985 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhuling (Grifola umbellata pilat)
Number of subjects: 146
Study 7842985 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 146
Study 7842985 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 146
Study 2896126 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous chlordesmethyldiazepam (1 mg)
Number of subjects: 6
Study 2896126 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral chlordesmethyldiazepam (tablets)
Number of subjects: 6
Study 2896126 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral chlordesmethyldiazepam (drops)
Number of subjects: 6
Study 29278044 — intervention group
Group type: EXPERIMENTAL
Intervention: additional moderate‐ to vigorous‐intensity physical activity (3 schools)
Number of subjects: 156
Study 29278044 — intervention group
Group type: EXPERIMENTAL
Intervention: additional light‐intensity physical activity (3 schools)
Number of subjects: 156
Study 29278044 — intervention group
Group type: EXPERIMENTAL
Intervention: restriction of light‐intensity physical activity and moderate‐ to vigorous‐intensity physical activity (3 schools)
Number of subjects: 156
Study 27610935 — intervention group
Group type: EXPERIMENTAL
Intervention: Snus
Number of subjects: 391
Study 27610935 — intervention group
Group type: COMPARATOR
Intervention: Nicotine gum
Number of subjects: 391
Study 25541227 — intervention group
Group type: EXPERIMENTAL
Intervention: 2g/day of plant stanols
Number of subjects: 182
Study 25541227 — intervention group
Group type: COMPARATOR
Intervention: unsupplemented yogurt (control)
Number of subjects: 182
Study 23339348 — intervention group
Group type: EXPERIMENTAL
Intervention: Urbanized Himba
Number of subjects: 0
Study 23339348 — intervention group
Group type: COMPARATOR
Intervention: Traditional Himba
Number of subjects: 0
Study 23339348 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive load imposed on traditional Himba
Number of subjects: 0
Study 23339348 — intervention group
Group type: EXPERIMENTAL
Intervention: Engaging stimuli/tasks
Number of subjects: 0
Study 20486620 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic remedies
Number of subjects: 0
Study 20486620 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 0
Study 20486620 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 17996006 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 microg/kg IV before remifentanil infusion (Group Pre)
Number of subjects: 100
Study 17996006 — intervention group
Group type: COMPARATOR
Intervention: Placebo before remifentanil infusion (Group Post)
Number of subjects: 100
Study 15850632 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine
Number of subjects: 0
Study 15850632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0